Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A-Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-Münster Study Group
暂无分享，去创建一个
G. Leverger | R. Gerbing | S. Ha | R. Masetti | J. Starý | J. Rubnitz | C. Harrison | H. D. de Groot-Kruseman | H. Hasle | B. De Moerloose | G. Kaspers | B. Buldini | M. Dworzak | C. Zwaan | A. Tierens | J. Abrahamsson | U. Norén-Nyström | Yilin Jiang | M. Rasche | N. Arad-Cohen | S. Elitzur | K. Klein | J. M. Fernández Navarro | C. Kelaidi | S. Polychronopoulou | H. Lapillonne | D. Tomizawa | T. Miyamura | E. Bart-Delabesse | B. Goemans | F. Locatelli | Romy E van Weelderen | Erin M. Guest | Nira Arad-Cohen | Kim Klein | Romy E. van Weelderen